GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Investments And Advances

Apollomics (Apollomics) Investments And Advances : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Investments And Advances?

Apollomics's Investments And Advances for the quarter that ended in Dec. 2023 was $0.00 Mil.

Apollomics's quarterly Investments And Advances declined from Dec. 2022 ($4.31 Mil) to Jun. 2023 ($0.00 Mil) but then stayed the same from Jun. 2023 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).

Apollomics's annual Investments And Advances declined from Dec. 2021 ($7.84 Mil) to Dec. 2022 ($4.31 Mil) and declined from Dec. 2022 ($4.31 Mil) to Dec. 2023 ($0.00 Mil).

Apollomics Investments And Advances Historical Data

The historical data trend for Apollomics's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Investments And Advances Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Investments And Advances
- 7.84 4.31 -

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Investments And Advances Get a 7-Day Free Trial 7.84 7.45 4.31 - -

Apollomics Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Investments And Advances
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLM:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.